ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
20 announcements
Dolphin Medical Services has notified BSE of a board meeting on 14 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results publication.
Dolphin Medical Services Ltd filed its quarterly shareholding pattern as mandated by SEBI Regulation 31(1)(b). This document provides no material business event.
Dolphin Medical Services appointed Mr. Kotha as Chairman and Promoter Director, reclassifying Mr. Mallour to Promoter Director. The board also reconstituted its committees.
Dolphin Medical Services scheduled a board meeting for September 21, 2026. The agenda includes board appointments, committee reconstitution, and promoter reclassification.
Dolphin Medical Services Limited announced the immediate resignation of its Managing Director and CEO, Mr. G V Mohan Prasad, and two other directors.
Dolphin Medical Services Ltd received Registrar of Companies approval to extend its Annual General Meeting deadline by two months. The meeting is now scheduled for November 30, 2026.
Acquirers Amarandhar Reddy Kotha and Mallour Rajesh Kumar completed an open offer for Dolphin Medical Services Limited. They acquired 18,000 shares at ₹4.80 each, totaling ₹0.01 Crore.
Dolphin Medical Services Ltd reported revenue from operations of ₹0.2 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
Dolphin Medical Services Limited has scheduled a board meeting for August 14, 2026, to consider and approve the unaudited standalone financial results for Q1 FY2026-27.
Rarever Financial Advisors has released the Letter of Offer for the acquisition of a 26% stake in Dolphin Medical Services Limited at ₹4.80 per share.
Dolphin Medical Services informed that its Board of Directors accepted the resignation of Mr. Vaishnavi Sharma from the positions of Company Secretary, Compliance Officer, and CFO.
Acquirers announced an open offer to acquire 26% of Dolphin Medical Services for ₹1.88 Crore. The identified date for shareholder eligibility is fixed as July 17, 2026.
Acquirers announced a ₹1.88 Crore open offer for a 26% stake in Dolphin Medical Services Limited. The offer price is set at ₹4.80 per share.
Dolphin Medical Services Limited submitted its Annual Secretarial Compliance Report for FY2026. The auditor confirmed full compliance with SEBI regulations with no observed deviations or fines.
Acquirers launched a ₹1.88 Crore open offer to acquire a 26% stake in Dolphin Medical Services Limited. The mandatory bid follows a share purchase agreement.
Dolphin Medical Services Ltd reported revenue from operations of ₹0.2 Cr (+100.0% YoY) and net profit of ₹0 Cr for Q4 FY26.
Dolphin Medical Services reported a total annual revenue of ₹0.79 Crore for FY26. The company turned profitable with a net profit of ₹0.04 Crore.
Dolphin Medical Services scheduled a board meeting for May 16, 2026. Directors will consider and approve audited financial results for the quarter and fiscal year.
Dolphin Medical Services Ltd announced the appointment of Mr. Kolachalama Saikumar and Smt. Srujana Siddhani as Independent Directors for five years. Simultaneously, the Board accepted the resignations of independent directors Mr. Narendra Seenakarkera, Mr. Vinay Vishnurajnayak, and Mr. Buddha Sagar Nanapaneni with immediate effect. These leadership changes aim to reconstitute the board's independent oversight.
Dolphin Medical Services Limited has scheduled a Board Meeting for April 22, 2026. The meeting will consider the appointment of Mr. Kolachalama Saikumar and Smt. Srujana Siddhani as Independent Directors, and the resignations of three directors, including Mr. Buddha Sagarnanapaneni. The board will also reconstitute various committees following these leadership changes.